logo-loader
Callitas Health Inc.

Callitas Therapeutics signs LOI with Simply Wholeistic, updates on THC & CBD candy patent

Callitas Therapeutics (CSE:LILY) (OTCQB:MPHMF) Vice President of Sales & Business Development Joshua Maurice tells Proactive Investors the pharma company has signed a letter of intent with Simply Wholeistic to manufacture  its CannaStrip products in the U.S.

Maurice added that as of today the Ohio-based company also received preliminary approval for a patent on a hard shell candy that delivers THC and CBD through oral absorption.

Quick facts: Callitas Health Inc.

Price: $0.11

Market: CSE
Market Cap: $3.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc. named herein, including the promotion by the Company of Callitas Health Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Callitas Health expects to roll out 'ToConcieve' product in the fourth quarter

Callitas Health (CSE:LILY, OTCQB:MPHMF, OTCMKTS: MPHMF) CEO James Thompson tells Proactive Investors that the clinical-stage pharmaceutical company is working through the R&D phase to get its ToConceive product onto retail shelves by the fourth quarter. In March, Callitas announced a...

on 11/7/18

2 min read